Deletion of peroxiredoxin 6 potentiates lipopolysaccharide-induced acute lung injury in mice

Crit Care Med. 2011 Apr;39(4):756-64. doi: 10.1097/CCM.0b013e318206befd.

Abstract

Objective: To investigate the role and signaling pathway of peroxiredoxin 6, a newly identified peroxidase, in lipopolysaccharide-induced acute lung injury.

Design: Prospective, randomized, controlled study.

Setting: Research laboratory.

Subjects: Peroxiredoxin 6 (-/-) and wild-type C57BL/6 mice.

Interventions: Wild-type or peroxiredoxin 6 (-/-) mice were challenged by intratracheal instillation of lipopolysaccharide (5 mg/kg) for 4 hrs or 24 hrs for lung injury measurement. In other studies, peritoneal macrophages, isolated from wild-type and peroxiredoxin 6 (-/-) mice, were preincubated in presence or absence of mitogen-activated protein kinases inhibitors for 30 mins before being stimulated with lipopolysaccharide (1 μg/mL) for 4 hrs.

Measurements and main results: Bronchoalveolar lavage myeloperoxidase activity and the lung injury score were significantly increased in peroxiredoxin 6 (-/-) mice compared with wild-type mice after lipopolysaccharide instillation at both 4 hrs and 24 hrs. Hydrogen peroxide and malondialdehyde levels, as well as nuclear factor-κB activities, tumor necrosis factor-α, interleukin-1β, and matrix metalloproteinase-9 messenger RNA, protein concentration, and activities were significantly increased whereas total antioxidative capability was markedly decreased in lungs of peroxiredoxin 6 (-/-) mice compared with wild-type mice. In vitro studies showed intracellular reactive oxygen species levels and release of tumor necrosis factor-α, interleukin-1, and matrix metalloproteinase-9 were significantly increased in macrophages from peroxiredoxin 6 (-/-) mice compared with that from wild-type mice after lipopolysaccharide stimulation. Cytokines release was partially suppressed by extracellular signal-regulated kinase and c-Jun N-terminal kinase inhibitors, but not by the p38 mitogen-activated protein kinase inhibitor.

Conclusions: Deletion of peroxiredoxin 6 exaggerates lipopolysaccharide-induced acute lung injury and inflammation with increased oxidative stress, inflammatory responses, and matrix degradation, all of which were partially dependent on nuclear factor-κB, extracellular signal-regulated kinase, and c-Jun N-terminal kinase pathways.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Lung Injury / etiology*
  • Acute Lung Injury / physiopathology
  • Animals
  • Hydrogen Peroxide / analysis
  • Interleukin-1beta / analysis
  • Lipopolysaccharides / pharmacology
  • Lung / chemistry
  • Lung / drug effects
  • Macrophages, Peritoneal / chemistry
  • Male
  • Malondialdehyde / analysis
  • Matrix Metalloproteinase 9 / analysis
  • Mice
  • Mice, Inbred C57BL
  • NF-kappa B / analysis
  • Oxidative Stress
  • Peroxiredoxin VI / deficiency
  • Peroxiredoxin VI / physiology*
  • Reactive Oxygen Species / analysis
  • Tumor Necrosis Factor-alpha / analysis

Substances

  • Interleukin-1beta
  • Lipopolysaccharides
  • NF-kappa B
  • Reactive Oxygen Species
  • Tumor Necrosis Factor-alpha
  • Malondialdehyde
  • Hydrogen Peroxide
  • Peroxiredoxin VI
  • Prdx6 protein, mouse
  • Matrix Metalloproteinase 9